BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2169831)

  • 1. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
    Niedbala MJ; Sartorelli AC
    Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
    Boyd D
    Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor for urokinase-plasminogen activator.
    Blasi F; Stoppelli MP; Cubellis MV
    J Cell Biochem; 1986; 32(3):179-86. PubMed ID: 3023408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A; Nolli ML; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
    Ossowski L
    Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line.
    George F; Pourreau-Schneider N; Arnoux D; Boutière B; Dussault N; Roux-Dosseto M; Alessi MC; Martin PM; Sampol J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):689-93. PubMed ID: 2133249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase receptors in lung cancer and normal lung.
    Veale D; Needham G; Harris AL
    Anticancer Res; 1990; 10(2A):417-21. PubMed ID: 2161199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine saturation of pro-urokinase receptors on human A431 cells.
    Stoppelli MP; Tacchetti C; Cubellis MV; Corti A; Hearing VJ; Cassani G; Appella E; Blasi F
    Cell; 1986 Jun; 45(5):675-84. PubMed ID: 3011276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant secretion by A431 cells of tissue plasminogen activator and a specific inhibitor masks EGF modulation of tPA activity.
    George F; Pourreau-Schneider N; Arnoux D; Boutière B; Berthois Y; Martin PM; Sampol J
    Thromb Haemost; 1990 Nov; 64(3):407-11. PubMed ID: 2128970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.
    Grøndahl-Hansen J; Ralfkiaer E; Kirkeby LT; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1991 Jan; 138(1):111-7. PubMed ID: 1702928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
    Min HY; Semnani R; Mizukami IF; Watt K; Todd RF; Liu DY
    J Immunol; 1992 Jun; 148(11):3636-42. PubMed ID: 1316922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A; Wohlwend A; Belin D; Schleuning WD; Vassalli JD
    J Biol Chem; 1989 Jan; 264(2):1180-9. PubMed ID: 2536017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
    Appella E; Robinson EA; Ullrich SJ; Stoppelli MP; Corti A; Cassani G; Blasi F
    J Biol Chem; 1987 Apr; 262(10):4437-40. PubMed ID: 3031025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H; Jensen PJ
    Cell Regul; 1990 Oct; 1(11):843-52. PubMed ID: 1965151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-dependent cell surface proteolysis and cancer.
    Blasi F; Verde P
    Semin Cancer Biol; 1990 Apr; 1(2):117-26. PubMed ID: 2151734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.